Analyst Andrew Tsai works at JEFFERIES and is focused on the Healthcare sector with 45 price targets and ratings documented since 2019 spanning on 6 stocks. Analyst's average stock valuation to be materialised ratio is 27.33% with an average time for price targets to be met of 119.4 days.
Most recent stock forecast was given on ATHA, Athira Pharma Inc. at 23-Jun-2022.
Andrew Tsai best performing recommendations are on XENE (XENON PHARMACEUTICALS INC).
The best stock recommendation documented was for XENE (XENON PHARMACEUTICALS INC) at 8/30/2021. The price target of $28 was fulfilled within 35 days with a profit of $11.09 (65.58%) receiving and performance score of 18.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
6
$2.2 (57.89%)
16
6 months 30 days ago
0/2 (0%)
$3.18 (47.87%)
Buy
3
$-0.8 (-21.05%)
40
7 months 14 days ago
2/6 (33.33%)
$15.33 (98.58%)
35
Buy
5
$1.2 (31.58%)
36
7 months 14 days ago
0/3 (0%)
$14.74 (129.13%)
16
$12.2 (321.05%)
1 years 1 months 21 days ago
0/1 (0%)
$4.06 (34.00%)
